Marlan D. Walker - Feb 18, 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Executive Officer
Signature
/s/ Marlan D. Walker
Stock symbol
TXMD
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
2/20/2025, 09:07 PM
Previous filing
Dec 7, 2023
Next filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise $0 +3.47K +5.54% $0.00 66K Feb 18, 2025 Direct
transaction TXMD Common Stock Options Exercise $0 +2.31K +3.5% $0.00 68.3K Feb 18, 2025 Direct
transaction TXMD Common Stock Options Exercise $0 +770 +1.13% $0.00 69.1K Feb 18, 2025 Direct
transaction TXMD Common Stock Options Exercise $0 +1.73K +2.51% $0.00 70.8K Feb 18, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Performance Stock Units Options Exercise $0 -3.47K -100% $0.00 0 Feb 18, 2025 Common Stock 3.47K $0.00 Direct F1
transaction TXMD Restricted Stock Units Options Exercise $0 -2.31K -100% $0.00 0 Feb 18, 2025 Common Stock 2.31K $0.00 Direct F2
transaction TXMD Restricted Stock Units Options Exercise $0 -770 -100% $0.00 0 Feb 18, 2025 Common Stock 770 $0.00 Direct F3
transaction TXMD Restricted Stock Units Options Exercise $0 -1.73K -50% $0.00 1.73K Feb 18, 2025 Common Stock 1.73K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.
F3 Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.
F4 Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.